학술논문

A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas
Document Type
Article
Source
In European Journal of Cancer August 2016 63:55-63
Subject
Language
ISSN
0959-8049